Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration
|更新时间:2025-01-16
|
Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration
“The latest research found that Huoluo Xiaoling Pill can significantly inhibit triple negative breast cancer, regulate immune cell subsets and enhance anti-tumor immunity by enhancing TCF1+CD8+stem cell like T cell tumor invasion and CD8+T cell activity.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 4, Pages: 108-115(2025)
LUO BO, ZHANG QU, SUN YUJIE, et al. Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration. [J]. Chinese journal of experimental traditional medical formulae, 2025, 31(4): 108-115.
DOI:
LUO BO, ZHANG QU, SUN YUJIE, et al. Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration. [J]. Chinese journal of experimental traditional medical formulae, 2025, 31(4): 108-115. DOI: 10.13422/j.cnki.syfjx.20242021.
Huoluo Xiaolingdan Suppresses Triple-negative Breast Cancer in Mice by Regulating TCF1+ CD8+ Stem Cell-like T Cells Infiltration